Skip to main content
Clinical Trials/NL-OMON33198
NL-OMON33198
Completed
Not Applicable

Prospective study on early immune response to factor VIII exposure in previously untreated patients with severe hemophilia A - PUPS

Academisch Medisch Centrum0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Bleeding disorder
Sponsor
Academisch Medisch Centrum
Enrollment
20
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Severe hemophilia A (factor VIII:C \<2%)
  • Previously untreated Patient
  • Minimally treated patient (\< 5 exposures to factor VIII concentrate)

Exclusion Criteria

  • Mild/moderate hemophilia A (factor VIII:C \> 2%)
  • Previously treated patient (\>5 exposures to factor VIII concetrate)

Outcomes

Primary Outcomes

Not specified

Similar Trials